Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
09/2007
09/27/2007WO2007107385A2 Soluble adenylate cyclase inhibitors
09/27/2007WO2007107384A2 Soluble adenylate cyclase inhibitors
09/27/2007WO2007107383A1 Indole derivatives as inhibitors of the soluble adenylate cyclase
09/27/2007WO2007089149A3 Water-soluble cc-1065 analogs and their conjugates
09/27/2007US20070225507 Process for preparing a crystalline form of Tegaserod maleate
09/27/2007US20070225506 Bactericides; 2-[(1R)-1-methyl-2-trityl-2,3-dihydro-1H-5-isoindolyl]-1,3,6,2-dioxazaborocane.
09/27/2007US20070225505 Method for the Preparation of (2S, 3AR, 7AS)-Octahydro-III-Indole-2-Carboxylic Acid as Key Intermediate in the Preparation of Trandolapril by Reacting a Cyclohexyl Aziridine with a Dialkyl Malonate
09/27/2007US20070225372 Amides as Bace Inhibitors
09/27/2007US20070225365 Cetp Inhibitors
09/27/2007US20070225352 methyl-[3-(2-nitro-phenylsulfanyl)-1-pyridin-2-ylmethyl-1H-indol-6-yl]-amine, possessing androgenic activity are useful in androgen-related treatments such as male hypogonadism, male and female hormone replacement therapy and male contraception
09/27/2007US20070225351 Methods and compositions for controlling body weight and appetite
09/27/2007DE102006014324A1 Inhibitoren der löslichen Adenylatzklase Inhibitors of soluble Adenylatzklase
09/27/2007DE102006014320A1 Inhibitoren der löslichen Adenylatzklase Inhibitors of soluble Adenylatzklase
09/27/2007DE102006014319A1 Inhibitoren der löslichen Adenylatzyklase Inhibitors of soluble adenylate cyclase
09/27/2007CA2647092A1 Indole derivatives as inhibitors of the soluble adenylate cyclase
09/27/2007CA2646650A1 Soluble adenylate cyclase inhibitors
09/27/2007CA2646594A1 Soluble adenylate cyclase inhibitors
09/27/2007CA2646229A1 Deuterated hepatitis c protease inhibitors
09/27/2007CA2646002A1 Salts with crth2 antagonist activity
09/27/2007CA2645426A1 1-oxo-isoindoline compounds for the treatment of spinal muscular atrophy and other uses
09/26/2007EP1837329A1 Novel heteroaryl derivative
09/26/2007EP1836167A2 Method to prepare bis(halophthalimides)
09/26/2007EP1836166A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
09/26/2007EP1338588B1 Method of resolving optical isomers of amino acid derivative
09/26/2007EP1276732B1 Amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation"
09/26/2007EP1261585B1 Substituted indole mannich bases
09/26/2007CN101044114A Nitrobenzindoles and their use in cancer therapy
09/26/2007CN101044113A Substituted indole compounds, their preparation and use in medicaments
09/26/2007CN101041633A Aromatic amine compound, and light-emitting element, light-emitting device, and electronic appliance using the aromatic amine compound
09/26/2007CN100339403C Halogen substituted catalyst system for olefin polymerization
09/26/2007CN100339377C Camptothecine derivative and its preparation
09/26/2007CN100339352C 2-and 2,5-substituted phenylketoenols
09/25/2007US7273951 Polyhydroxy phenols and their use in binding p-selectin
09/25/2007US7273885 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
09/25/2007US7273878 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor
09/25/2007US7273863 Benzophenones as inhibitors of reverse transcriptase
09/25/2007US7273857 Fused ring compounds substituted with a 8-azabicyclo[3.2.1]octane(cyclo)alkylene group, including benzothiazolones, e.g., 3-[3-(3-Propyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-3H-benzothiazol-2-one; highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes
09/25/2007CA2415551C Aniline derivatives
09/25/2007CA2389766C New indenoindolone derivatives, the procedure for preparing them and the pharmaceutical compounds that contain them
09/25/2007CA2294278C Chalcones having antiproliferative activity
09/25/2007CA2256516C Peptides
09/25/2007CA2243317C Novel fused pyrrolecarboxamides; a new class of gaba brain receptor ligands
09/20/2007WO2007106564A2 Synthesis of thrombopoietin activity modulating compounds
09/20/2007WO2007106525A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases
09/20/2007WO2007106469A2 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
09/20/2007WO2007106329A2 Low pressure carbonylation of heterocycles
09/20/2007WO2007105989A2 1-oxo-3-(1h-indole)-3-il-1,2,3,4-tetrahydroisoxynolines, methods for the production thereof, combinatoric library and focused library
09/20/2007WO2007105340A1 Compound and method of using the same, organic el element, process for producing the same, and use method
09/20/2007WO2007105336A1 Methine dye and use thereof
09/20/2007WO2007105297A1 Methine dye and use thereof
09/20/2007WO2007104685A1 Use of aryl- or alkyloxy-substituted phthalocyanines as marking substances for liquids
09/20/2007WO2007104582A1 Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
09/20/2007WO2007104383A1 Tegaserod hemimaleate and a process for its preparation
09/20/2007WO2007104214A1 Camptothecin derivatives and their use
09/20/2007US20070219233 Substituted Indoles and Their Use as Integrin Antagonists
09/20/2007US20070219216 1-Alkylpiperazinyl-Pyrrolidin-2,5-Dione Derivatives as Adrenergic Receptor Antagonists
09/20/2007US20070219215 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both
09/20/2007US20070219209 Piperazine Derivatives Of Alkyl Oxindoles
09/20/2007US20070219202 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease
09/20/2007US20070218502 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation
09/20/2007US20070215889 Aromatic amine compound, and light-emitting element, light-emitting device, and electronic appliance using the aromatic amine compound
09/20/2007CA2646430A1 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
09/20/2007CA2646232A1 Synthesis of thrombopoietin activity modulating compounds
09/20/2007CA2646205A1 Use of aryl- or alkyloxy-substituted phthalocyanines as markers for liquids
09/20/2007CA2646154A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases
09/20/2007CA2637597A1 Tetrahydronaphthalene derivatives, processes for preparing them and their use as anti-inflammatory agents
09/19/2007EP1834947A2 3-substituted amino-1H-indole-2-carboxylic acid and 3-substituted amino-benzo[B]thiophene-2carboxylic acid derivatives as interleukin-4 gene expression inhibitors
09/19/2007EP1833797A1 Azacyclic compounds as inhbitors of sensory neurone specific channels (sns)
09/19/2007EP1833791A2 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
09/19/2007EP1833790A1 Process for the preparation of alkyl 5-(dicarboximido)levulinate and alkyl 4-oxo-pentenoate
09/19/2007EP1833789A1 Process for the preparation of enantiomerically enriched indoline-2-carboxylic acid
09/19/2007EP1833788A1 Process for preparing perindopril erbumine
09/19/2007EP1833787A2 Indole derivatives for use as ppar active compounds
09/19/2007EP1799641A4 Process for the preparation of amorphous fluvastatin sodium
09/19/2007EP1406605B1 Carbamates of 2-heterocyclic-1,2-ethanediols
09/19/2007EP1198456B1 Potassium channel openers
09/19/2007EP0977767B1 Aminooxy-modified oligonucleotides
09/19/2007CN101039909A Carbazole derivative, and light emitting element and light emitting device using the carbazole derivative
09/19/2007CN101039908A Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
09/19/2007CN101039907A Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
09/19/2007CN100338077C Combretastatin A-4 phosphate prodrug, mono-and di-organic amine salt, mono-and di-amino acids salts, and mono-and di-amino acid ester salt
09/19/2007CN100338066C Hexacyclic compounds
09/19/2007CN100338055C Carbamates of 2-heterocyclic-1, 2-ethanediols
09/19/2007CN100338044C HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
09/19/2007CN100338036C Substd. indolinones having inhibiting effect on kinases and cycline/CDK complexes
09/19/2007CN100337996C method for synthesis of (2s)-indoline-2-carboxylic acid and use in the synthesis of perindopril
09/19/2007CN100337751C Hydroxylation of beta-dicarbonyls with zirconium catalysts
09/18/2007US7271265 Cyanine compounds and their application as quenching compounds
09/18/2007US7271192 Nitrogen oxide synthase inhibitors; synthesis
09/18/2007US7271190 Indazole compounds as β3 adrenoceptor agonist
09/18/2007US7271180 1-Aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
09/18/2007US7271164 Therapy , prevention of obsessive-complusive disorders; antidepressants; anxiety; schizophrenia; eating disorders; obesity; antiepileptic agents central nervous system disorders; sleep disorders
09/18/2007US7271163 Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
09/18/2007US7271162 Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
09/18/2007US7270752 Process for purifying lactams
09/18/2007CA2220533C 3-amidochromanylsulfonyl(thio)ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them
09/13/2007WO2007103389A2 Aldolases, nucleic acids encoding them and methods for making and using them
09/13/2007WO2007102563A1 Method for determination of the effect of thrombin receptor antagonist by determination of inflammatory marker
09/13/2007WO2007102392A1 Mmp-13-selective inhibitor
09/13/2007WO2007102069A1 Improved prodrugs of cc-1065 analogs